NB30
Aminoglycoside capable of translational readthrough
General information
N/A
Synonyms
N/A
Marketed as
N/A
Dietary sources
N/A
Structure image not available
N/A
Drug-Mutation Relation
results for W1282X / R792X
See all data on NB30Treats
| Mutation | Link | Tested on | Impact factor | Notes |
|---|---|---|---|---|
| W1282X | Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. | human cell cultures | 4.67 | |
| W1282X | Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. | in vitro | 5.21 | Less effective than NB54, gentamicin or paromomycin individually. Less toxic than gentamicin or paromomycin. |
Does not treat
| Mutation | Link | Tested on | Impact factor | Notes |
|---|